Research & Recognition

Peer-Reviewed Publications

  • Multiplexed Capillary-Flow Driven Immunoassay for Respiratory Illnesses

  • Flow control in a laminate capillary-driven microfluidic device

  • Capillary driven microfluidic sequential flow device for point-of-need ELISA: COVID-19 serology testing

  • Capillary flow-driven Immunoassay Platform for COVID-19 Antigen Diagnostics

Grants

  • This funding, through Colorado’s Advanced Industries Accelerator Program, supports early-stage companies developing high-impact technologies. This grant helps advance CaDI platform development.

  • This NIH SBIR Phase I grant supports the development of an ultrasensitive, low-cost, rapid, saliva-based strep test utilizing CaDI.

    Award Number: 1R43AI172708-01A1

  • This grant, through SPARK-REACH/NIH RADx, supported the development of COVID-19 testing at Colorado State University and helped accelerate the early development of the CaDI platform during the pandemic.

    Award Number: 5U01HL152405-04  

  • This grant provides NIH support to conduct usability testing and pilot clinical studies for our saliva-based Strep A test. The project is a collaboration with the ACME POCT program, Emory University, Children’s Healthcare of Atlanta, and Georgia Tech, and is focused on advancing user-friendly diagnostic solutions for clinical settings.

Global Intellectual Property Portfolio